The Enterprise Value as of December 2025 (TTM) for Nektar Therapeutics (0UNL.L) is 1.16B

According to Nektar Therapeutics’s latest financial reports and current stock price. The company's current Enterprise Value is 1.16B. This represents a change of 132.41% compared to the average of 501.09M of the last 4 quarters.

Nektar Therapeutics (0UNL.L) Historical Enterprise Value (quarterly & annually)

How has 0UNL.L Enterprise Value performed in the past?

The mean historical Enterprise Value of Nektar Therapeutics over the last ten years is 3.04B. The current 1.16B Enterprise Value has changed 3.73% with respect to the historical average. Over the past ten years (40 quarters), 0UNL.L's Enterprise Value was at its highest in in the March 2018 quarter at 17.31B. The Enterprise Value was at its lowest in in the September 2023 quarter at 169.72M.

Nektar Therapeutics (0UNL.L) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Nektar Therapeutics Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Nektar Therapeutics (0UNL.L) Average Enterprise Value

How has 0UNL.L Enterprise Value performed in the past?

The current Enterprise Value of Nektar Therapeutics (0UNL.L) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Nektar Therapeutics (0UNL.L) Enterprise Value vs. Peers

How is 0UNL.L’s Enterprise Value compared to its peers?

Nektar Therapeutics’s Enterprise Value is greater than OPKO Health, Inc. (1.04B), less than Dynavax Technologies Corporation (1.46B), greater than Intellia Therapeutics, Inc. (850.28M), less than AxoGen, Inc. (1.39B), greater than Verastem, Inc. (502.77M), greater than Geron Corporation (915.15M), greater than Anavex Life Sciences Corp. (258.01M), greater than Iovance Biotherapeutics, Inc. (650.41M), greater than Myriad Genetics, Inc. (752.67M), less than Teladoc Health, Inc. (1.64B),

Build a custom stock screener for Nektar Therapeutics (0UNL.L) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nektar Therapeutics using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Nektar Therapeutics (0UNL.L) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Nektar Therapeutics or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.